How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,452 results for

Intrauterine Growth Retardation

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. L-arginine in Treatment of Intrauterine Growth Restriction

L-arginine in Treatment of Intrauterine Growth Restriction L-arginine in Treatment of Intrauterine Growth Restriction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. L-arginine in Treatment of Intrauterine (...) provided by (Responsible Party): Hayam Fathy Mohammad, Ain Shams University Study Details Study Description Go to Brief Summary: Intrauterine growth restriction is an important problem in neonatal care. Intrauterine growth restriction (IUGR) is defined as a fetal weight below the 10th percentile for gestational age. One of the main causes of IUGR is placental insufficiency. Nitric oxide(NO) increases placental blood flow. So,it might be useful to improve IUGR pregnancy outcome . Condition or disease

2017 Clinical Trials

42. Treatment of Intrauterine Growth Restriction With Low Molecular Heparin.

and ischemic placental lesions [ Time Frame: 13 weeks maximum ] Measured as the presence of one or more of the following: Intrauterine growth retardation (Neonatal weight below the 10th percentile of our population + umbilical artery pulsatility index during the third trimester (on two separate occasions> 48h) above the 95th percentile), Preeclampsia, Gestational age (weeks) at birth, Premature delivery before 34 weeks of gestation, Urgent cesarean section due to loss of fetal well-being, Neonatal weight (...) Treatment of Intrauterine Growth Restriction With Low Molecular Heparin. Treatment of Intrauterine Growth Restriction With Low Molecular Heparin. - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Treatment

2017 Clinical Trials

43. Evaluation of Fetal Cardiac Function and Vascular Hemodynamics in Intrauterine Growth Restriction

Evaluation of Fetal Cardiac Function and Vascular Hemodynamics in Intrauterine Growth Restriction Evaluation of Fetal Cardiac Function and Vascular Hemodynamics in Intrauterine Growth Restriction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove (...) one or more studies before adding more. Evaluation of Fetal Cardiac Function and Vascular Hemodynamics in Intrauterine Growth Restriction The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT03108040 Recruitment Status

2017 Clinical Trials

44. Ted (G.J.) Kloosterman: on intrauterine growth. The significance of prenatal care. Studies on birth weight, placental weight and placental index. (PubMed)

Ted (G.J.) Kloosterman: on intrauterine growth. The significance of prenatal care. Studies on birth weight, placental weight and placental index. In the last century, there was a heated debate on whether fetal growth retardation is caused by a small placenta or whether a placenta is small because the baby is small. One of the active participants in this debate was Kloosterman who studied 80,000 birth weights, and 30,000 placental weights, in relation to gestational age at birth, fetal sex (...) , maternal parity, and perinatal mortality. He found that pregnancies related to heavier placentas last longer. He also found that, from about 32 weeks of gestation onwards, children from primiparous women as compared to those from multiparous women, like twin children as compared to singleton children, are relatively growth retarded, most likely related to prior relatively poor placental growth. He concluded that poor fetal growth is not the cause, but the result of poor placental growth. The clinical

2017 Placenta

45. Intrauterine Growth Retardation

Intrauterine Growth Retardation Imaging in Intrauterine Growth Retardation: Overview, Ultrasonography Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvNDA0MDk4LW92ZXJ2aWV3 processing > Imaging in Intrauterine Growth (...) Retardation Updated: Nov 12, 2015 Author: Vikram S Dogra, MD; Chief Editor: Eugene C Lin, MD Share Email Print Feedback Close Sections Sections Imaging in Intrauterine Growth Retardation Overview Overview The term intrauterine growth restriction has largely replaced the term intrauterine growth retardation (IUGR). The definition of IUGR is a problematic one because we do not know the inherent growth potential of the fetus. The most common definition used is fetal weight below the 10th percentile

2014 eMedicine Radiology

46. Intrauterine Growth Restriction: Antenatal and Postnatal Aspects (PubMed)

Intrauterine Growth Restriction: Antenatal and Postnatal Aspects Intrauterine growth restriction (IUGR), a condition that occurs due to various reasons, is an important cause of fetal and neonatal morbidity and mortality. It has been defined as a rate of fetal growth that is less than normal in light of the growth potential of that specific infant. Usually, IUGR and small for gestational age (SGA) are used interchangeably in literature, even though there exist minute differences between them (...) . SGA has been defined as having birth weight less than two standard deviations below the mean or less than the 10th percentile of a population-specific birth weight for specific gestational age. These infants have many acute neonatal problems that include perinatal asphyxia, hypothermia, hypoglycemia, and polycythemia. The likely long-term complications that are prone to develop when IUGR infants grow up includes growth retardation, major and subtle neurodevelopmental handicaps, and developmental

Full Text available with Trip Pro

2016 Clinical medicine insights. Pediatrics

47. Detection of expressional changes induced by intrauterine growth restriction in the developing rat pancreas (PubMed)

Detection of expressional changes induced by intrauterine growth restriction in the developing rat pancreas Intrauterine growth retardation (IUGR) is a disorder that can result in permanent changes in the physiology and metabolism of the newborn, which increased the risk of disease in adulthood. Evidence supports IUGR as a risk factor for the development of diabetes mellitus, which could reflect changes in pancreas developmental pathways. We sought to characterize the IUGR-induced alterations

Full Text available with Trip Pro

2016 Experimental Biology and Medicine

48. Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth Restriction

Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth Restriction Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth Restriction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. Sildenafil Citrate for the Management of Asymmetrical Intrauterine Growth Restriction The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02678221 Recruitment Status : Unknown Verified February 2016 by Omar Mamdouh Shaaban, Assiut University. Recruitment status was: Not yet recruiting First

2016 Clinical Trials

49. First Trimester Placental Assessment in the Screening of Preeclampsia and Intrauterine Growth Restriction

volume First-trimester screening Ultrasound Preeclampsia Intrauterine growth restriction Biochemical markers Uterine artery doppler Additional relevant MeSH terms: Layout table for MeSH terms Pre-Eclampsia Fetal Growth Retardation Hypertension, Pregnancy-Induced Pregnancy Complications Fetal Diseases Growth Disorders Pathologic Processes Angiogenesis Inhibitors Angiogenesis Inducing Agents Angiogenesis Modulating Agents Growth Substances Physiological Effects of Drugs Growth Inhibitors Antineoplastic (...) First Trimester Placental Assessment in the Screening of Preeclampsia and Intrauterine Growth Restriction First Trimester Placental Assessment in the Screening of Preeclampsia and Intrauterine Growth Restriction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100

2016 Clinical Trials

50. Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction

Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before (...) adding more. Low-molecular-weight Heparin in Constituted Vascular Intrauterine Growth Restriction (GROWTH) The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. of clinical studies and talk to your health care provider before participating. Read our for details. ClinicalTrials.gov Identifier: NCT02672566 Recruitment Status : Recruiting First Posted : February 3

2016 Clinical Trials

51. The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction

The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one (...) or more studies before adding more. The Effect of Omega 3 on Pregnancy Complicated by Asymmetrical Intrauterine Growth Restriction The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02696577 Recruitment Status : Completed First Posted : March 2, 2016 Last Update Posted : March 15, 2016 Sponsor: Assiut

2016 Clinical Trials

52. Impetigo Herpetiformis Complicated with Intrauterine Growth Restriction Treated Successfully with Granulocyte and Monocyte Apheresis. (PubMed)

Impetigo Herpetiformis Complicated with Intrauterine Growth Restriction Treated Successfully with Granulocyte and Monocyte Apheresis. 27573023 2017 03 20 2017 05 05 1651-2057 97 3 2017 03 10 Acta dermato-venereologica Acta Derm. Venereol. Impetigo Herpetiformis Complicated with Intrauterine Growth Restriction Treated Successfully with Granulocyte and Monocyte Apheresis. 410-411 10.2340/00015555-2527 Saito-Sasaki Natsuko N Department of Dermatology, University of Occupational and Environmental (...) Health, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu , 807-8555, Japan. natsuko-saito@med.uoeh-u.ac.jp. Izu Kunio K Sawada Yu Y Hino Ryosuke R Nakano Ryoji R Shimajiri Shohei S Nishimura Izumi I Nakamura Hiromasa H Sugiura Kazumitsu K Nakamura Motonobu M eng Case Reports Journal Article Sweden Acta Derm Venereol 0370310 0001-5555 IM Biopsy Dermatitis Herpetiformis blood diagnosis therapy Female Fetal Growth Retardation blood diagnosis immunology therapy Granulocytes immunology Humans Impetigo blood

Full Text available with Trip Pro

2016 Acta Dermato-Venereologica

53. Choline supplementation improves the lipid metabolism of intrauterine-growth-restricted pigs (PubMed)

Choline supplementation improves the lipid metabolism of intrauterine-growth-restricted pigs The objective of this study was to investigate the effects of dietary choline supplementation on hepatic lipid metabolism and gene expression in finishing pigs with intrauterine growth retardation (IUGR).Using a 2×2 factorial design, eight normal birth weight (NBW) and eight IUGR weaned pigs were fed either a basal diet (NBW pigs fed a basal diet, NC; IUGR pigs fed a basal diet, IC) or a diet

Full Text available with Trip Pro

2016 Asian-Australasian journal of animal sciences

54. Effectiveness and cost-effectiveness of routine third trimester ultrasound screening for intrauterine growth restriction: study protocol of a nationwide stepped wedge cluster-randomized trial in The Netherlands (The IRIS Study). (PubMed)

Effectiveness and cost-effectiveness of routine third trimester ultrasound screening for intrauterine growth restriction: study protocol of a nationwide stepped wedge cluster-randomized trial in The Netherlands (The IRIS Study). Intrauterine growth retardation (IUGR) is a major risk factor for perinatal mortality and morbidity. Thus, there is a compelling need to introduce sensitive measures to detect IUGR fetuses. Routine third trimester ultrasonography is increasingly used to detect IUGR (...) practices will be included at 22 weeks of gestation. In the intervention (n = 7,500) and control group (n = 7,500) fetal growth will be monitored by serial fundal height assessments. All practices will start offering the control condition (ultrasonography based on medical indication). Every three months, 20 practices will be randomized to the intervention condition, i.e. apart from ultrasonography if indicated, two routine ultrasound examinations will be performed (at 28-30 weeks and 34-36 weeks

Full Text available with Trip Pro

2016 BMC Pregnancy and Childbirth Controlled trial quality: uncertain

55. Prematurity, intrauterine growth retardation and low birth weight: risk factors in a malaria-endemic area in southern Benin. (PubMed)

Prematurity, intrauterine growth retardation and low birth weight: risk factors in a malaria-endemic area in southern Benin. The aim of this study was to describe the contribution of prematurity and small for gestational age (SGA) to low birth weight (LBW) as well as to identify risk factors associated with preterm birth and SGA and to explore their impact on birth weight.A cross-sectional study was carried out in southern Benin between June 2007 and July 2008. At delivery, women's

2013 Transactions of the Royal Society of Tropical Medicine & Hygiene

56. Paternal GNAS mutations lead to severe intrauterine growth retardation (IUGR) and provide evidence for a role of XLαs in fetal development. (PubMed)

Paternal GNAS mutations lead to severe intrauterine growth retardation (IUGR) and provide evidence for a role of XLαs in fetal development. Heterozygous GNAS inactivating mutations cause pseudohypoparathyroidism type Ia (PHP-Ia) when maternally inherited and pseudopseudohypoparathyroidism (PPHP)/progressive osseous heteroplasia (POH) when paternally inherited. Recent studies have suggested that mutations on the paternal, but not the maternal, GNAS allele could be associated with intrauterine (...) growth retardation (IUGR) and thus small size for gestational age.The aim of the study was to confirm and expand these findings in a large number of patients presenting with either PHP-Ia or PPHP/POH.We collected birth parameters (ie, gestational age, weight, length, and head circumference) of patients with either PHP-Ia (n = 29) or PPHP/POH (n = 26) with verified GNAS mutations. The parental allele carrying the mutation was assessed by investigating the parents or, when a de novo mutation

Full Text available with Trip Pro

2013 Journal of Clinical Endocrinology and Metabolism

57. Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation

Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding (...) more. Growth Hormone Treatment of Children Diagnosed of Intrauterine Growth Retardation The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT01697644 Recruitment Status : Completed First Posted : October 2, 2012 Last Update Posted : January 18, 2017 Sponsor: Novo Nordisk A/S Information provided

2012 Clinical Trials

58. The impact of doppler sonography on intrauterine management and neonatal outcome in preterm fetuses with intrauterine growth retardation. (PubMed)

The impact of doppler sonography on intrauterine management and neonatal outcome in preterm fetuses with intrauterine growth retardation. To test the hypothesis that earlier delivery may be warranted to improve neonatal outcome of fetuses with intrauterine growth restriction (IUGR) with abnormal Doppler parameters.This was a retrospective cohort study of 110 fetuses with an antenatal diagnosis of IUGR due to placental insufficiency which had a very low birth weight (< 1500 g), delivered

Full Text available with Trip Pro

2011 Ultrasound in Obstetrics and Gynecology

59. Impairment of cellular immunity is associated with overexpression of heat shock protein 70 in neonatal pigs with intrauterine growth retardation (PubMed)

Impairment of cellular immunity is associated with overexpression of heat shock protein 70 in neonatal pigs with intrauterine growth retardation Neonates with intrauterine growth retardation (IUGR) are susceptible to decreases in cellular immunity. In recent years, a growing body of evidence indicates that Hsp70 may serve as a danger signal to the innate immune system and promote receptor-mediated apoptosis. Using neonatal pigs with IUGR, we investigated immune function of pigs and expression

Full Text available with Trip Pro

2012 Cell stress & chaperones

60. Heat Shock Protein 70 Expression is Increased in the Liver of Neonatal Intrauterine Growth Retardation Piglets (PubMed)

Heat Shock Protein 70 Expression is Increased in the Liver of Neonatal Intrauterine Growth Retardation Piglets Intrauterine growth retardation (IUGR) leads to the dysfunction in digestive system, as well as the alteration in the expression of some functional proteins. Heat shock protein 70 (Hsp70) could be induced by various stress factors, but whether Hsp70 expression is changed in neonatal IUGR infants has not been demonstrated. This study was conducted to explore the expression of Hsp70

Full Text available with Trip Pro

2012 Asian-Australasian journal of animal sciences

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>